Your browser doesn't support javascript.
loading
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.
Khorashad, Jamshid S; Eiring, Anna M; Mason, Clinton C; Gantz, Kevin C; Bowler, Amber D; Redwine, Hannah M; Yu, Fan; Kraft, Ira L; Pomicter, Anthony D; Reynolds, Kimberly R; Iovino, Anthony J; Zabriskie, Matthew S; Heaton, William L; Tantravahi, Srinivas K; Kauffman, Michael; Shacham, Sharon; Chenchik, Alex; Bonneau, Kyle; Ullman, Katharine S; O'Hare, Thomas; Deininger, Michael W.
  • Khorashad JS; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Eiring AM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Mason CC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Gantz KC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Bowler AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Redwine HM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Yu F; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT; Beijing Tsinghua Chang Gung Hospital, Tsinghua University, Beijing, China;
  • Kraft IL; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Pomicter AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Reynolds KR; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Iovino AJ; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Zabriskie MS; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Heaton WL; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • Tantravahi SK; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT;
  • Kauffman M; Karyopharm Therapeutics, Natick, MA; and.
  • Shacham S; Karyopharm Therapeutics, Natick, MA; and.
  • Chenchik A; Cellecta, Mountain View, CA.
  • Bonneau K; Cellecta, Mountain View, CA.
  • Ullman KS; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT;
  • O'Hare T; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT;
  • Deininger MW; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT;
Blood ; 125(11): 1772-81, 2015 Mar 12.
Article en En | MEDLINE | ID: mdl-25573989
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Transporte Activo de Núcleo Celular / ARN Interferente Pequeño Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Transporte Activo de Núcleo Celular / ARN Interferente Pequeño Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article